Breast cancer is frequent and life threatening, but curable if detected early. For accurate early detection, imaging results (e.g. ultrasound, mammography) and image understanding must be optimised so that the possibility for over-diagnosis is reduced. The FP7 project, VPH-PRISM (Virtual Physiological Human: Personalised Predictive Breast Cancer Therapy Through Integrated Tissue Micro-Structure Modeling) will allow for the modelling of breast tissue microstructure, combining multiple disciplines and scales as well as other factors (environmental, genetic and clinical) that can impact breast cancer progression. With these models in place, a better understanding of breast cancer will be available for each patient; allowing for personalised diagnosis and ensuring the most effective and efficient treatment is used.

VPH-PRISM, in collaboration with the ASSURE project, will host a session at ECR 2016:

Thursday, March 3, 14:00-15:30 – Studio 2016
Joint VPH-PRISM/ASSURE Session – from screening to therapy: innovative breast care concepts

View the session flyer here.

Chairperson: Horst Hahn

Introduction: challenges and innovative approaches in image-based breast care (10′)
Horst K. Hahn; Bremen/DE

Breast cancer risk, density patterns, and masking in screening mammograms (15′)
Carla van Gils; Utrecht/NL

Novel ultrasound and MRI technologies for breast cancer screening (15′)
Nico Karssemeijer; Nijmegen/NL

Breast Cancer Risk and Masking Risk-based Stratification Protocols: Key drivers of cost-effectiveness (15′)
Ewan Gray; Manchester/UK

Histopathology images: the new kid on the block of clinical multimodality imaging (15′)
Jeroen van der Laak; Nijmegen/NL

For more information on VPH-PRISM, join the session and stop by the EIBIR booth at ECR 2016 near the main entrance, or visit the project’s website at www.vphprism.eu.

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 601040.